| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -92.8% |
| R&D Expense | $58.0M | +28.7% |
| SG&A Expense | $31.5M | +4.5% |
| Operating Income | -$143.4M | -226.7% |
| Pre-tax Income | -$139.5M | -80.8% |
| Income Tax | -$9.2M | -3303.1% |
| Net Income | -$130.3M | -68.3% |
| EPS (Basic) | -$5.02 | -12.1% |
| EPS (Diluted) | -$5.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.1M | -41.1% |
| Accounts Receivable | $1.1M | +27.9% |
| Current Assets | $129.3M | -40.3% |
| Total Assets | $296.4M | -31.9% |
| Current Liabilities | $14.9M | -35.0% |
| Total Liabilities | $422.7M | -4.3% |
| Stockholders' Equity | -$126.2M | -1755.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.9M | -212.3% |
| Capital Expenditures | $5.5M | -40.0% |
| Investing Cash Flow | -$5.5M | +37.6% |
| Financing Cash Flow | -$8.1M | -104.8% |
| Free Cash Flow | -$79.4M | -142.3% |
| -11.8% |